In the middle of autumn, in the picturesque and colourful atmosphere of Moldavian nature, the neurological community of the country had the chance to organize and participate in one of the most important and valuable scientific event of the Society… Continue Reading

on behalf of the Bulgarian Society of Neurosonology and Cerebral Hemodynamics, I would like to express our gratitude towards the European Academy of Neurology for the honor to organize for a second time the Regional Teaching Course of Neurology in Sofia, Bulgaria from October 6th - 8th, 2017.

November 22, 2017 – European Parliament, Brussels Access to quality healthcare is a basic citizen’s right – yet it is still not a reality for all of us. Large health inequalities persist in the EU and many patients do not… Continue Reading

The new CME article November 2017: “Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort” is online now! Please log-in and browse to the LEARN  section on the EAN Website and answer the… Continue Reading

It is not new that human disease is imposing a burden on the sufferers and a challenge for the physician. While neurologists are having the privilege being physicians and have the single patient in our focus of attention, health economists take a different view. Their thinking is focusing on the burden of disease for the society and its economic implications. They look at the costs of disease in different terms. The classical measures for the burden of disease are the costs in terms of disability-adjusted life years (DALYs) which are defined as the sum of years of life lost due to the disease (YLLs) and years lived with the disease (YLDs) accounting for reduced life time with good quality of life due to the disability. Another important measure is the Socio-demographic Index (SDI) reflecting economic and educational development. There is big science behind all these calculations which I will not go into detail here.

  The EAN Specialist Panel “Neurocritical Care” held its annual meeting on the 25th June 2017 during the EAN Congress in Amsterdam. Chair: Maxwell Damian. Management Group members present: Erich Schmutzhard and Raimund Helbok. The Chair welcomed the attendees and… Continue Reading

  SP Neuroimaging met during recent EAN Congress in Amsterdam. Co-chairs Massimo Filippi from Italy and Irena Rektorova from Czech Republic reviewed Panel activities at the EAN congresses and announced proposals which have been selected for the Lisbon 2018 congress:… Continue Reading

Please find below articles from Cypriot authors and co-authors that were published in the European Journal of Neurology

Situated at the north-eastern end of the Mediterranean basin, Cyprus is the third largest island in the region, with an area of 9,251 square kilometers (3,572 square miles). Cyprus is a small island with a long history and a rich culture that spans 10,000 years, making it one of the oldest civilizations in the Mediterranean area. Situated at the crossroads of three continents - Europe, Asia and Africa - the island’s unique geographic position has played an important part in its turbulent past since antiquity. The island was divided in 1974 following the Turkish invasion.

David B. Vodušek (DBV): The Scientific Panel for Health – SPH is an official and unique panel of the EC within H2020. Can you introduce the SPH to the readers of EAN and explain its tasks? Karin Sipido (KS): The European Commission’s Scientific Panel for Health is a science-led expert group based on the provisions of the Horizon2020 Specific Programme.

For November 2017, we have selected: Mittal S, Bjørnevik K, Im DS, et al. ß2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease. Science 2017;140:2295-2305. Disturbed proteostasis of α-synuclein is now thought to play a critical role in the pathogenesis of Parkinson’s disease (PD). Physiological functions of this protein include synaptic transport as well as involvement in the metabolism of membrane phospholipids, and in the differentiation and survival of dopaminergic neurons.